American parents tired of worrying about classroom outbreaks and sick of telling their primary school-age children no to sleepovers and family gatherings have felt a wave of relief when Pfizer asked the US Government to authorise its COVID-19 vaccine for youngsters aged 5 to 11.
If US regulators give the go-ahead, reduced-dose kids’ shots could begin within a matter of weeks.That could bring many families a step closer to being done with remote learning, virus scares and repeated school shutdowns and quarantines.
“My son asked about playing sports. ‘After you’re vaccinated.’ He asked about seeing his cousins again. ‘After you’re vaccinated.’ A lot of our plans are on hold,” said Sarah Staffiere of Waterville, Maine, whose seven-year-old has a rare immune disease that has forced the family to be extra cautious throughout the pandemic.”When he’s vaccinated, it would give our family our lives back,” she said.Expanding vaccine availability to roughly 28 million more US children is seen as another milestone in the fight against the virus and comes amid an alarming rise in serious infections in youngsters because of the extra-contagious Delta variant.
It would also push the US vaccination drive further ahead of much of the rest of the world at a time when many poor countries are desperately short of vaccine.The Food and Drug Administration must decide whether the shots are safe and effective in younger children.
Many parents and pediatricians are clamoring for protection for youngsters under 12, the current age cutoff for COVID-19 vaccinations in the US.But there are also plenty of parents who are wary about getting the shot themselves and are in no hurry to have their children vaccinated.Heather Miller, a mother of four from Dexter, Maine, said she wants to wait for follow-up studies on the vaccine. “I’m not 100 per cent against getting it eventually, but I kind of fall into the ‘not right now, wait and see’ category,” she said.Cindy Schilling, an elementary school principal in West Virginia, which ranks dead last in the percentage of fully vaccinated residents, said it has been a rough start to the year because so many children are testing positive or quarantining at different times, making it hard for teachers and students to stay on track.While children are at lower risk of severe illness or death than older people, COVID-19 does sometimes kill them — at least 520 so far in the US, according to the American Academy of Pediatrics.
Pfizer and its German partner BioNTech said their research shows younger children should get one-third of the dose now given to everyone else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody levels just as strong as those that teens and young adults get from regular-strength shots.On October 26, an independent expert panel that advises the FDA will publicly debate the evidence. If the FDA authorises emergency use of the children-size doses, the Centers for Disease Control and Prevention will make a final decision, after hearing from its outside advisers.To avoid mix-ups, Pfizer is planning to ship the lower-dose vials specially marked for use in children.